Current funding

  • MYC-alarmin axis as a novel therapeutic vulnerability in myelofibrosis

    NCI R01 Grant

    PI Seongseok Yun MD PhD

    6/1/2024-5/30/2029

  • Strategic therapeutic targeting to overcome Venetoclax resistance in acute myeloid leukemia

    ASCO CDA Grant

    PI Seongseok Yun MD PhD

    7/1/2022-6/30/2025

  • Tumor suppressor roles of TFEB in the development and maintenance of myeloid leukemia

    NCI K08 Grant

    PI Seongseok Yun MD PhD

    9/1/2019-8/31/2024

  • The role of MYC in age related myeloid neoplasms

    Southeast Trust

    PI Seongseok Yun MD PhD

    1/1/2024-12/31/2024

  • MYC-alarmin axis as a novel therapeutic vulnerability in myelofibrosis

    ASH Scholar Award

    PI Nicole Vincelette PhD

    7/1/2023-6/30/2025

  • The role of c-MYC and TFEB in the acute myeloid leukemia leukemogenesis

    ASH Scholar Award

    PI Seongseok Yun MD PhD

    7/1/2019-4/30/2023

  • The roles of alarmins in cardiovascular disease associated with clonal hematopoiesis

    Miles for Moffitt Pilot Grant

    PI Seongseok Yun MD PhD

    1/1/2023-12/31/2023